European Companies Search Engine
EU funding (€1,590,408): Photocatalytic Industrial Applications Hor10 Jun 2024 EU Research and Innovation programme "Horizon"
Overview
Text
Photocatalytic Industrial Applications
The European Union has been challenged to contribute to the global aim of providing sustainable solutions to the current and future needs on synthetic compounds and materials in the coming years. In this sense, the development of sustainable chemical processes is one of the most important features in modern chemistry. It has become a key research area worldwide, providing solutions to important societal demands by optimizing the use of natural resources and minimizing waste and environmental impact. Among the relevant methods for achieving this goal, catalysis represents a key and central approach. Both Organocatalysis and Metal Catalysis have emerged as solutions to the problems in this context. Despite the enormous advances made towards both types of catalysis, the development of more efficient and general catalysts, as well as synthetic methods is still a challenge. A very similar research-road has occurred in the Photocatalysis area, using visible-light as mild and sustainable energy source. In this context, the pharmaceutical industry has a great impact in our society. Well-stablished organo- and, especially, metal-catalysis have been largely implemented in the chemical industry, both on a micro and ton scale. However, there are only few timid academic applications of novel photocatalytic visible light methodologies into industrial goals. Therefore, the development of cheaper and straightforward methodologies to the incorporation of key photochemical processes is an important field and has a tremendous impact in the industry field. Therefore, greater blending of academia and industry would be desirable for the implementation of photocatalysis in the chemical industry world. Students who can access this doctoral network will have the opportunity to work in European Funded academic researchers and in three Big Pharma companies in a hot field such as photocatalysis with the aim to develop new real industrial solutions.
Funded Companies:
| Company name | Funding amount |
| Universite Paris-Saclay | ? |
| Centre National de la Recherche Scientifique CNRS | €282,694 |
| Glaxosmithkline Investigacion y Desarrollo SL | €0.00 |
| Pcas | €282,694 |
| SANOFI-AVENTIS DEUTSCHLAND GmbH | €260,539 |
| Synthelia Organics SL | €251,971 |
| Universidad Autonoma de Madrid | €251,971 |
| UNIVERSITAET MUENSTER | €260,539 |
Source: https://cordis.europa.eu/project/id/101168878
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Universite Paris-Saclay, Gif-sur-Yvette, France.
The visualizations for "Universite Paris-Saclay - EU funding (€1,590,408): Photocatalytic Industrial Applications"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
